UC San Diego Health First to Offer Novel Gene Therapy for Hemophilia B
UC San Diego Health one of a few health care systems on West Coast to offer new gene therapy for hemophilia B.
UC San Diego Health one of a few health care systems on West Coast to offer new gene therapy for hemophilia B.
Researchers at UC San Diego School of Medicine are serving as the central data hub for the CHARM Network, a new five-year pandemic preparedness initiative funded by the CDC. This includes ensuring real-time public access to results on the incidence of the most common respiratory infections.
According to a new study from researchers at UC San Diego, ketamine use has risen significantly since 2015. The results highlight the need for closer monitoring of recreational ketamine use.
Much of our knowledge of the protein PD-1, a leading cancer treatment target, comes from studies in mice. In a comprehensive assessment of PD-1, researchers have found that PD-1 in mice is significantly weaker than the human version, providing new information on how cancer treatments are developed.
UC San Diego Health rehabilitation and prosthesis training help patient thrive with use of bionic hand after electrocution accident.
An enzyme called MICAL2 promotes tumor growth and metastasis in the most common form of pancreatic cancer, according to a new study by UC San Diego School of Medicine researchers.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
You have been successfully subscribed to the UC San Diego Today Newsletter.